Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage AREC Q3 2025 Earnings SmallerThanExpected Loss Signals Operational Progress PGY Q1 2026 Earnings Massive EPS Beat Drives Investor Interest Despite Share Dip MNPR Q1 2026 Earnings Surprise EPS Beat in PreRevenue Biotech CHA Q4 2025 Earnings EPS Misses Estimates by Wide Margin SWIM Q1 2026 Earnings EPS Beats Expectations by 527 Despite Negative Print